Unal Mutlu1,2, Johanna M Colijn1,2, M Arfan Ikram1,3,4, Pieter W M Bonnemaijer1,2, Silvan Licher1, Frank J Wolters1, Henning Tiemeier1,5, Peter J Koudstaal1,4, Caroline C W Klaver1,2,6, M Kamran Ikram1,4. 1. Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands. 2. Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands. 3. Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands. 4. Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands. 5. Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands. 6. Department of Ophthalmology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
Abstract
Importance: Retinal structures may serve as a biomarker for dementia, but longitudinal studies examining this link are lacking. Objective: To investigate the association of inner retinal layer thickness with prevalent and incident dementia in a general population of Dutch adults. Design, Setting, and Participants: From September 2007 to June 2012, participants from the prospective population-based Rotterdam Study who were 45 years and older and had gradable retinal optical coherence tomography images and at baseline were free from stroke, Parkinson disease, multiple sclerosis, glaucoma, macular degeneration, retinopathy, myopia, hyperopia, and optic disc pathology were included. They were followed up until January 1, 2015, for the onset of dementia. Exposures: Inner retinal layer thicknesses (ie, retinal nerve fiber layer [RNFL]) and ganglion cell-inner plexiform layer (GC-IPL) thicknesses measured on optical coherence tomography images. Main Outcomes and Measures: Odds ratios and hazard ratios for incident dementia per SD decrease in retinal layer thickness adjusted for age, sex, education, and cardiovascular risk factors. Results: Of 5065 individuals eligible for optical coherence tomography scanning, 3289 (64.9%) (mean [SD] age 68.9 [9.9] years, 1879 [57%] women) were included in the analysis. Of these 3289 individuals, 41 (1.2%) already had dementia. Thinner GC-IPL was associated with prevalent dementia (odds ratio per SD decrease in GC-IPL, 1.37 [95% CI, 0.99-1.90]). No association was found of RNFL with prevalent dementia. During 14 674 person-years of follow-up (mean [SD], 4.5 [1.6] years), 86 individuals (2.6%) developed dementia of whom 68 (2.1%) had Alzheimer disease. Thinner RNFL at baseline was associated with an increased risk of developing dementia (hazard ratio per SD decrease in RNFL, 1.44 [95% CI, 1.19-1.75]), which was similar for Alzheimer disease (hazard ratio, 1.43 [95% CI, 1.15-1.78]). No association was found between GC-IPL thickness and incident dementia (hazard ratio, 1.13 [95% CI, 0.90-1.43]). Conclusions and Relevance: Thinner RNFL is associated with an increased risk of dementia, including Alzheimer disease, suggesting that retinal neurodegeneration may serve as a preclinical biomarker for dementia.
Importance: Retinal structures may serve as a biomarker for dementia, but longitudinal studies examining this link are lacking. Objective: To investigate the association of inner retinal layer thickness with prevalent and incident dementia in a general population of Dutch adults. Design, Setting, and Participants: From September 2007 to June 2012, participants from the prospective population-based Rotterdam Study who were 45 years and older and had gradable retinal optical coherence tomography images and at baseline were free from stroke, Parkinson disease, multiple sclerosis, glaucoma, macular degeneration, retinopathy, myopia, hyperopia, and optic disc pathology were included. They were followed up until January 1, 2015, for the onset of dementia. Exposures: Inner retinal layer thicknesses (ie, retinal nerve fiber layer [RNFL]) and ganglion cell-inner plexiform layer (GC-IPL) thicknesses measured on optical coherence tomography images. Main Outcomes and Measures: Odds ratios and hazard ratios for incident dementia per SD decrease in retinal layer thickness adjusted for age, sex, education, and cardiovascular risk factors. Results: Of 5065 individuals eligible for optical coherence tomography scanning, 3289 (64.9%) (mean [SD] age 68.9 [9.9] years, 1879 [57%] women) were included in the analysis. Of these 3289 individuals, 41 (1.2%) already had dementia. Thinner GC-IPL was associated with prevalent dementia (odds ratio per SD decrease in GC-IPL, 1.37 [95% CI, 0.99-1.90]). No association was found of RNFL with prevalent dementia. During 14 674 person-years of follow-up (mean [SD], 4.5 [1.6] years), 86 individuals (2.6%) developed dementia of whom 68 (2.1%) had Alzheimer disease. Thinner RNFL at baseline was associated with an increased risk of developing dementia (hazard ratio per SD decrease in RNFL, 1.44 [95% CI, 1.19-1.75]), which was similar for Alzheimer disease (hazard ratio, 1.43 [95% CI, 1.15-1.78]). No association was found between GC-IPL thickness and incident dementia (hazard ratio, 1.13 [95% CI, 0.90-1.43]). Conclusions and Relevance: Thinner RNFL is associated with an increased risk of dementia, including Alzheimer disease, suggesting that retinal neurodegeneration may serve as a preclinical biomarker for dementia.
Authors: Yosef Koronyo; David Biggs; Ernesto Barron; David S Boyer; Joel A Pearlman; William J Au; Shawn J Kile; Austin Blanco; Dieu-Trang Fuchs; Adeel Ashfaq; Sally Frautschy; Gregory M Cole; Carol A Miller; David R Hinton; Steven R Verdooner; Keith L Black; Maya Koronyo-Hamaoui Journal: JCI Insight Date: 2017-08-17
Authors: Yoo Young Hoogendam; Albert Hofman; Jos N van der Geest; Aad van der Lugt; Mohammad Arfan Ikram Journal: Eur J Epidemiol Date: 2014-02-20 Impact factor: 8.082
Authors: G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman Journal: Neurology Date: 1993-02 Impact factor: 9.910
Authors: Unal Mutlu; Pieter W M Bonnemaijer; M Arfan Ikram; Johanna M Colijn; Lotte G M Cremers; Gabriëlle H S Buitendijk; Johannes R Vingerling; Wiro J Niessen; Meike W Vernooij; Caroline C W Klaver; M Kamran Ikram Journal: Neurobiol Aging Date: 2017-09-14 Impact factor: 4.673
Authors: Manuel Vidal-Sanz; Caridad Galindo-Romero; Francisco J Valiente-Soriano; Francisco M Nadal-Nicolás; Arturo Ortin-Martinez; Giuseppe Rovere; Manuel Salinas-Navarro; Fernando Lucas-Ruiz; Maria C Sanchez-Migallon; Paloma Sobrado-Calvo; Marcelino Aviles-Trigueros; María P Villegas-Pérez; Marta Agudo-Barriuso Journal: Front Neurosci Date: 2017-04-26 Impact factor: 4.677
Authors: Natascha Merten; Adam J Paulsen; A Alex Pinto; Yanjun Chen; Lauren K Dillard; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Carla R Schubert; Karen J Cruickshanks Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-16 Impact factor: 6.053
Authors: Sophia Ling Li; Ka Wai Kam; Arnold Shau Hei Chee; Xiu Juan Zhang; Li Jia Chen; Wilson W K Yip; Clement C Tham; Alvin L Young; Ian C K Wong; Patrick Ip; Jason C Yam Journal: Int Ophthalmol Date: 2021-05-20 Impact factor: 2.031
Authors: Victor T T Chan; Zihan Sun; Shumin Tang; Li Jia Chen; Adrian Wong; Clement C Tham; Tien Y Wong; Christopher Chen; M Kamran Ikram; Heather E Whitson; Eleonora M Lad; Vincent C T Mok; Carol Y Cheung Journal: Ophthalmology Date: 2018-08-13 Impact factor: 12.079
Authors: Dejan Jakimovski; Ralph H B Benedict; Bianca Weinstock-Guttman; Osman Ozel; Tom A Fuchs; Norah Lincoff; Niels Bergsland; Michael G Dwyer; Robert Zivadinov Journal: J Neurol Date: 2021-02-15 Impact factor: 4.849
Authors: Christopher Kai Shun Leung; Alexander Ka Ngai Lam; Robert Neal Weinreb; David F Garway-Heath; Marco Yu; Philip Yawen Guo; Vivian Sheung Man Chiu; Kelvin Ho Nam Wan; Mandy Wong; Ken Zhongheng Wu; Carol Yim Lui Cheung; Chen Lin; Carmen Kar Mun Chan; Noel Ching Yan Chan; Ka Wai Kam; Gilda Wing Ki Lai Journal: Nat Biomed Eng Date: 2022-01-06 Impact factor: 25.671
Authors: Ward Fickweiler; Emily A Wolfson; Samantha M Paniagua; Marc Gregory Yu; Atif Adam; Vanessa Bahnam; Konstantina Sampani; I-Hsien Wu; Gail Musen; Lloyd P Aiello; Hetal Shah; Jennifer K Sun; George L King Journal: J Clin Endocrinol Metab Date: 2021-03-25 Impact factor: 5.958
Authors: Peter J Snyder; Jessica Alber; Clemens Alt; Lisa J Bain; Brett E Bouma; Femke H Bouwman; Delia Cabrera DeBuc; Melanie C W Campbell; Maria C Carrillo; Emily Y Chew; M Francesca Cordeiro; Michael R Dueñas; Brian M Fernández; Maya Koronyo-Hamaoui; Chiara La Morgia; Roxana O' Carare; Srinivas R Sadda; Peter van Wijngaarden; Heather M Snyder Journal: Alzheimers Dement Date: 2020-10-08 Impact factor: 21.566